A small biotech firm was trying to determine the impact of how changes in the influenza viral genome impact a patient’s response to an antiviral drug. The client came to us with a request to build out a single dataset that combines subject data, virologic data, and viral genotypic and phenotypic resistance data. Each data category needed to contain a single metric, statistic or category with uniform format and units. The information needed to be organized in the specific format that would be acceptable to the FDA. The client did not have the resources and expertise to build the dataset in-house.
お問合せはこちら